The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maroto, R.
Right arrow Articles by König, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maroto, R.
Right arrow Articles by König, R.
The Journal of Immunology, 1999, 162: 5973-5980.
Copyright © 1999 by The American Association of Immunologists

Requirement for Efficient Interactions Between CD4 and MHC Class II Molecules for Survival of Resting CD4+ T Lymphocytes In Vivo and for Activation-Induced Cell Death1

Rosario Maroto, Xiaoli Shen and Rolf König2

Department of Microbiology and Immunology and Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, TX 77555


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Regulation of homeostasis in the immune system includes mechanisms that promote survival of resting T lymphocytes, and others that control activation-induced cell death (AICD). In this study, we report on the use of a transgenic mouse model to test the role of CD4-MHC class II interactions for the susceptibility of CD4+ T lymphocytes to AICD, and for the survival of resting CD4+ T cells in peripheral lymphoid organs. The only I-Aß gene expressed in these mice is an Aßk transgene with a mutation that prevents MHC class II molecules from interacting with CD4. We show increased apoptosis in CD4+ T lymphocytes derived from wild-type, but not from mutant Aßk transgenic mice following stimulation with staphylococcal enterotoxin A. Therefore, AICD may be impaired in CD4+ T cells derived from mutant Aßk transgenic mice. Importantly, we observed much higher apoptosis in resting CD4+ T cells from mutant Aßk transgenic mice than from wild-type mice. Furthermore, resting CD4+ T cells from mutant Aßk transgenic mice expressed higher levels of cell surface CD95 (Fas, APO-1). Ab-mediated cross-linking of CD95 further increased apoptosis in CD4+ T cells from mutant Aßk transgenic mice, but not from wild-type mice, suggesting apoptosis involved CD95 signaling. When cocultured with APC-expressing wild-type MHC class II molecules, apoptosis in resting CD4+ T lymphocytes from mutant Aßk transgenic mice was reduced. Our results show for the first time that interactions between CD4 and MHC class II molecules are required for the survival of resting CD4+ T cells in peripheral lymphoid organs.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
During thymic development, T lymphocytes segregate into two phenotypically and functionally distinct classes, distinguished by expression of either CD4 or CD8 surface glycoproteins. Interactions between these transmembrane glycoproteins and MHC molecules participate in regulating differentiation of thymocytes into mature single-positive (CD4+CD8- or CD4-CD8+) T lymphocytes (1, 2, 3, 4, 5). Reactivity of mature T cells to MHC class I and MHC class II Ags is closely associated with expression of CD8 and CD4, respectively (6, 7, 8). Direct interactions between CD4 or CD8 and relatively monomorphic regions of the polymorphic MHC molecules participate in and contribute to T cell activation (9, 10, 11, 12, 13). CD4 and CD8 act as coreceptors that form a multimeric signaling machinery with the Ag-specific TCR and the CD3/{zeta}2 complex (14, 15, 16). However, it is still unknown which T cell signaling pathways are activated by the interaction of the coreceptors with their MHC ligands.

Interactions between CD8 and MHC class I molecules are required for both positive and negative selection of CD4-CD8+ T lymphocytes in the thymus (3, 4, 5). A requirement for CD4-MHC class II interactions for positive, but not for negative, selection has been demonstrated in mice that express a E137A/V142A mutant I-Aß transgene, and whose MHC class II molecules are therefore incapable of interacting with CD4 (17, 18). However, despite the inability of heterodimeric molecules that consist of endogenous I-A{alpha} and E137A/V142A mutant I-Aß to interact with CD4, some CD4+CD8- thymocytes mature and exit into peripheral lymphoid tissues in these mutant I-Aß transgenic mice (17, 18). Furthermore, we reported that mutant Aßk transgenic mice can mount Th cell-dependent immune responses, and that their CD4+ T cells secrete IFN-{gamma}, but are deficient in IL-2 production (18). Because interactions between the TCR and MHC class II molecules remain, but CD4-MHC class II interactions are abolished, this system allows us to further elucidate the role of CD4 in maintaining peripheral CD4+ T cells.

In addition to its function as a coreceptor that enhances TCR-mediated signals, CD4 may directly participate in the control of peripheral T cell responses (e.g., Th-subtype differentiation, long-term survival, tolerance, apoptosis). For example, blocking CD4 with mAbs (19) or CD4-interacting peptides (20) inhibits activation-induced cell death (AICD).3 On the other hand, in vitro exposure of resting human CD4+ T cells to anti-CD4 Abs or HIV can prime the cells for apoptosis induced by secondary signaling through the TCR (21, 22) or homing receptors (23). Moreover, cross-linking of CD4 molecules on the surface of human primary resting T cells by anti-CD4 Abs or HIV gp120 is sufficient to induce CD95-mediated apoptosis (24).

These prior observations suggested that CD4+ T cells activated in E137A/V142A mutant Aßk transgenic mice may be less susceptible to AICD. In this work, we demonstrate that CD4+ T lymphocytes from E137A/V142A mutant Aßk transgenic mice proliferate, but show no increase in the apoptotic index in response to in vitro stimulation through the TCR, consistent with resistance to AICD. However, unstimulated CD4+ T cells from E137A/V142A mutant Aßk transgenic mice undergo apoptosis at a much higher rate than do CD4+ T lymphocytes from wild-type Aßk transgenic mice. Our results show for the first time that interactions between CD4 and MHC class II molecules are required for survival of resting CD4+ T cells in peripheral lymphoid organs.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Materials

All chemicals, of the highest purity available, were purchased from Sigma (St. Louis, MO), unless otherwise stated. Staphylococcal enterotoxin A (SEA) was from Toxin Technologies (Madison, WI). Tissue culture media and supplements were from Life Technologies (Gaithersburg, MD).

Media and cell lines

DMEM containing 5% heat-inactivated FCS, 2 mM L-glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 10 mM HEPES, and 50 µM 2-ME were used for all cell culture experiments with mouse lymphocytes. This medium is henceforth called D5. The anti-mouse CD4 hybridoma GK1.5, the anti-mouse CD8 hybridoma 2.43, the anti-mouse MHC class II hybridoma 39E, and the IL-2-dependent indicator cell line CTLL-2 were obtained from the American Type Culture Collection (Manassas, VA) and cultured according to their recommendations.

Generation of transgenic mice

The generation of transgenic mice expressing wild-type or mutant Aßk has been described (18). Briefly, the double mutation Ala for Glu137 and Ala for Val142 was introduced into Aßk cDNA using PCR (12). Wild-type and mutant Aßk cDNAs were cloned into the pDOI plasmid within the rabbit ß-globin gene under control of the E{alpha} promoter (25). Fragments containing the E{alpha} promoter, the Aßk wild-type or mutant cDNA, and a polyadenylation site were excised with BglI. Fragments free of vector sequences were used for microinjection into fertilized eggs from (C57BL/6 x SJL)F2 mice. Founder lines that transmitted the transgene were established. Transgenic mice were bred to Aß0/0 mice. The only MHC class II molecules expressed on the cell surface in these lines are A{alpha}bAßk heterodimers. Lines that displayed normal tissue distribution of expression were selected. Henceforth, the wild-type Aßk transgenic line will be referred to as W+ Aßk, and the mutant line as M Aßk. Transgenic mice were maintained in a conventional animal care facility (accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International), according to the Public Health Service Policy on Humane Care and Use of Laboratory Animals.

Isolation and culture of cells from lymph nodes and spleens

Cell suspensions from lymph nodes (LNs) and spleens were prepared as described (18, 26). Cells used for functional analyses were always isolated by negative selection. Briefly, purified populations of CD4+ T lymphocytes and CD4-depleted splenocytes were prepared by incubating with specific Abs (2.43, anti-CD8 mAb; 39E, anti-MHC class II mAb; GK1.5, anti-CD4 mAb), followed by incubation with anti-IgG Ab-coated magnetic beads (Dynabeads M-450; Dynal, Oslo, Norway), and magnetic depletion (26). Cell purity was routinely tested by fluorescence-activated flow cytometry using a FACScan (Becton Dickinson, Mountain View, CA).

In vitro culture of lymphocytes, axillary, brachial, cervical, inguinal, popliteal, and mesenteric LNs were dissected from unprimed mice. To measure apoptosis, we incubated LN cell preparations in 24-well plates at 2 x 106 cells/well in 0.8 ml of D5 at 37°C and 7% CO2. Alternatively, cell preparations were depleted of MHC class II+ and CD8+ cells with mAb 39E and 2.43, respectively (26). CD4-enriched preparations were incubated at 1–2 x 106 cells/well with 1–2 x 106 T cell-depleted splenocytes from either W+ Aßk or M Aßk mice. Cytokine production and cellular proliferation were measured as described previously (18, 26). Briefly, LN T cells (LNTCs) were incubated in flat-bottom 96-well plates at 1 x 106 cells/well in 0.2 ml of D5. To measure cellular proliferation, 1 µCi of [3H]thymidine was added 16 h before harvesting cells on a Packard Filtermate 196 cell harvester (Packard, Downers Grove, IL). Incorporated radioactivity was measured in a Packard Direct Matrix Beta Counter with a counting efficiency of 5%. Concentrations of secreted IL-2 were measured by determining the ability of a 1/4 dilution of culture supernatants to support growth of the IL-2-dependent cell line CTLL-2.

Flow-cytometric analysis and apoptosis assay

Apoptosis was measured by two- and three-color flow cytometry on a FACScan (Becton Dickinson). Cell preparations (1–2 x 106 cells) were stained with R-PE-labeled anti-CD4 mAb (Caltag, South San Francisco, CA) and FITC-labeled Annexin V (Boehringer Mannheim, Indianapolis, IN), according to the manufacturer’s recommendations. Viable lymphocytes were electronically gated on forward and side scatter parameters characteristic for lymphocytes. In addition, viable cells were gated on their ability to exclude the dye 7-amino actinomycin D (27, 28). Expression of CD95 and the IL-2R {alpha}-chain (IL-2R{alpha}, CD25) was measured by staining with fluorescein-labeled anti-CD95 mAb Jo2 (PharMingen, San Diego, CA) and fluorescein-labeled anti-CD25 mAb 7D4 (PharMingen), respectively. Acquired data were analyzed with the CellQuest program (Becton Dickinson).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Lack of AICD in CD4+ T lymphocytes from E137A/V142A MHC class II mutant mice

Activation of naive CD4+ T lymphocytes by Ag or bacterial superantigens can cause peripheral deletion of mature T lymphocytes (29, 30). We have reported previously that interference with CD4-MHC class II interactions using synthetic peptides that correspond to the CD4 binding site on the MHC class II ß2-domain blocks AICD (20). Therefore, we hypothesized that the E137A/V142A mutation in Aßk may prevent cell death in CD4+ T lymphocytes induced by activation with SEA. To test this idea, we measured in vitro effects of SEA on CD4+ LNTCs from W+ and M Aßk mice.

Apoptotic cells are rapidly cleared from circulation in vivo (31). However, an early and ubiquitous event in cells undergoing apoptosis is exposure of phosphatidylserine at the cell surface (32). In nonapoptotic cells, phosphatidylserine is located on the cytoplasmic side of the plasma membrane. Cell surface-exposed phosphatidylserine can be detected by a phospholipid-binding protein, Annexin V (32, 33). Thus, fluorescence-activated flow cytometry can be used to measure apoptosis. Viable apoptotic CD4+ cells can be detected by Annexin V staining and their ability to exclude the dye 7-amino actinomycin D (28). Using this technique, we could measure the apoptotic index in freshly isolated CD4+ LNTCs and after in vitro culture.

Activation-induced apoptosis was detectable in lymphocytes from W+ Aßk mice 72 h after stimulation with SEA, showing an increase in a dose- and time-dependent manner in CD4+ LNTCs from W+ Aßk, but not from M Aßk mice (Fig. 1Go). We could not detect any differences in the apoptotic index of CD4+LNTCs from M Aßk mice whether the cells were incubated with SEA up to 5 µg/ml or without SEA. However, it was readily apparent that in unstimulated CD4+ LNTCs from M Aßk mice, apoptosis was enhanced as compared with CD4+LNTCs from W+ Aßk mice (Fig. 1Go).



View larger version (30K):
[in this window]
[in a new window]
  		FIGURE 1. The apoptotic index in CD4+ T lymphocytes from E137A/V142A mutant Aßk transgenic mice does not increase following stimulation with superantigen. Lymphocytes were incubated in the absence or presence of SEA (0.5 and 5 µg/ml) at 2 x 106 cells/well in 800 µl of D5 media in 24-well plates. The percentage of apoptotic CD4+ LNTCs from W+ Aßk and M Aßk mice after incubation for 72 and 96 h (A and B, respectively) was determined by two-color flow cytometry using R-PE-labeled anti-CD4 mAb and FITC-labeled Annexin V. Viable lymphocytes were electronically gated based on their forward and side light scatter characteristics. Data represent the mean ± SD of three to six independent experiments. Student’s unpaired t test was used to test whether data significantly differed from the unstimulated control (without SEA) of the same mouse strain. *, p < 0.05; **, p < 0.01.

 
The E137A/V142A mutation in MHC class II does not prevent activation of CD4+ T lymphocytes

One possible explanation for the lack of AICD in CD4+ T lymphocytes from M Aßk mice following SEA stimulation was that the mutation in MHC class II prevented activation of CD4+ T cells. Although CD4+ LNTCs from M Aßk mice could proliferate in response to stimulation with bacterial superantigen, they required 10- to 100-fold higher concentrations of SEA for responses equivalent to those observed in CD4+ LNTCs from W+ Aßk mice (Fig. 2GoA). However, when incubated longer, LNTCs from M Aßk mice reached proliferation rates comparable with LNTCs from W+ Aßk mice, even in response to low SEA concentrations (Fig. 2GoB). Therefore, LNTCs from M Aßk mice could be activated by SEA, and thus lack of AICD in CD4+ LNTCs from M Aßk mice was not due to an inability to respond to SEA.



View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 2. Lymphocytes from both W+ Aßk and M Aßk mice proliferate in response to SEA. Lymphocytes were incubated at 1 x 106 cells/well in 200 µl of D5 media with various concentrations of SEA in flat-bottom 96-well plates for various lengths of time, and pulsed with 1 µCi of [3H]thymidine for the last 16 h of incubation. Cells were then harvested, and incorporated radioactivity was measured in a Packard Direct Matrix Beta Counter (efficiency of counting = 6%). A, Proliferative response induced by increasing concentrations of SEA (from 0.005 to 5 µg/ml) in lymphocytes from W+ Aßk and M Aßk mice after incubation for 48 h. B, Time course of lymphocyte proliferation after stimulation with 5 ng/ml of SEA. Data are expressed as the mean ± SD of triplicates, and are representative of three independent experiments.

 
CD4+ T lymphocytes from E137A/V142A MHC class II mutant mice are deficient in IL-2 production

Maximal levels of IL-2 in cultures of SEA-stimulated LNTCs from W+ and M Aßk mice differed by almost 5-fold. Cultures of LNTCs from M Aßk mice never achieved IL-2 concentrations similar to those found in W+ Aßk cultures (Fig. 3Go). Even at the highest SEA concentrations used, IL-2 levels were very low in cultures of LNTCs from M Aßk mice. Furthermore, we could not detect cytoplasmic IL-2 by intracellular staining in CD4+LNTCs from M Aßk mice after 4 or 24 h of SEA stimulation, whereas a large proportion of CD4+ LNTCs from wild-type mice contained intracellular IL-2 after 4 h of SEA stimulation (not shown). These data confirmed previous observations made in the M Aßk mice using SEA and the protein Ag, keyhole limpet hemocyanin (18).



View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 3. Lack of IL-2 secretion by lymphocytes from M Aßk mice in response to SEA. Lymphocytes were incubated at 1 x 106 cells/well in 200 µl of D5 media with various concentrations of SEA in flat-bottom 96-well plates. Culture supernatants were collected after 48 (A), 72 (B), and 96 (C) h of incubation. IL-2 concentrations were determined by the ability of a 1/4 dilution of the supernatants to support the growth of the IL-2-dependent cell line CTLL-2. Data are expressed as the mean ± SD of triplicates, and are representative of three independent experiments. D, Endogenous IL-2 enhances AICD in SEA-stimulated CD4+ LNTCs from W+ Aßk and M Aßk transgenic mice. Lymphocytes were incubated with 5 µg/ml of SEA in the presence or absence of exogenous IL-2 (20 U/ml) for 72 h. Apoptotic cells in the CD4+ T cell population were measured as described in the legend to Fig. 1Go. When cultured in the presence of IL-2, the mean FITC-fluorescence intensity of viable SEA-stimulated CD4+ T lymphocytes increased 1.4-fold and 2.1-fold for LNTCs derived from W+ Aßk and M Aßk mice, respectively. Data are from two independent experiments.

 
Because IL-2 has been reported to promote AICD (34), it was possible that a dearth in IL-2 secretion prevented AICD in SEA-stimulated LNTCs from M Aßk mice. To test this possibility, we incubated LNTCs from W+ and M Aßk mice with SEA (5 µg/ml) in the presence or absence of exogenous IL-2 (20 U/ml) for 72 h. Exogenous IL-2 enhanced apoptosis in SEA-stimulated CD4+ LNTCs from both W+ and M Aßk mice (Fig. 3GoD), suggesting that insufficient IL-2 production was responsible for the lack of AICD in LNTCs from M Aßk mice.

Enhanced apoptosis in resting CD4+ T lymphocytes from E137A/V142A MHC class II mutant mice

During the experiments conducted to determine whether the E137A/V142A mutation in MHC class II would affect AICD in CD4+ LNTCs, we observed a higher percentage of apoptotic cells in resting CD4+ LNTCs from M Aßk mice than in CD4+ LNTCs from W+ Aßk mice (Fig. 1Go). It was suggested previously that survival of resting CD4+ T lymphocytes in vivo may depend on interactions with MHC class II-expressing cells (35). Because our mouse model introduced only a mutation in the CD4 binding site of Aßk without affecting Ag-presenting functions of the MHC class II molecule, it was ideally suited to determine whether CD4+ T lymphocytes required CD4-MHC class II interactions for survival. Therefore, we measured the proportion of apoptotic CD4+ T cells in freshly isolated LNs from W+ and M Aßk mice.

The number of apoptotic CD4+ LNTCs was 2- to 3-fold higher in lymphocyte populations freshly isolated from M Aßk mice than in lymphocytes from W+ Aßk mice (Fig. 4GoA, 0 time point). This suggested that in vivo, apoptosis-inducing signals were delivered at a higher rate in M Aßk than in W+ Aßk mice. Furthermore, when LN cell preparations were cultured in vitro without Ag stimulation, this difference in the apoptotic index between CD4+ LNTCs from M Aßk and W+ Aßk mice remained (Fig. 4Go). Because apoptotic cells eventually shrink and lose their cell membrane integrity, we used electronic gating, based on cell size and ability to exclude 7-amino actinomycin D, to eliminate dead cells. Therefore, our results suggested that rates of apoptosis differed between CD4+ LNTCs from the two mouse strains.



View larger version (26K):
[in this window]
[in a new window]
  		FIGURE 4. Enhanced apoptosis in CD4+ T lymphocytes from M Aßk mice. A, The percentage of apoptotic CD4+ LNTCs in freshly isolated LN cells (0 time) and after various lengths of in vitro culture (48–96 h) was measured by two-color flow cytometry using R-PE-labeled anti-CD4 mAb and FITC-labeled Annexin V. Viable lymphocytes were electronically gated, based on their forward and side light scatter characteristics. Data represent the mean ± SD of three to six independent experiments. Similar data were obtained by three-color flow cytometry and additional gating of viable cells on their ability to exclude 7-amino actinomycin D. The percentage of apoptotic CD4+ LNTCs in lymphocytes from W+ Aßk and M Aßk mice was compared using Student’s unpaired t test. **, p < 0.01; ***, p < 0.001. B, Freshly isolated LN cells from M Aßk mice were stained with anti-CD4 mAb-R-PE, Annexin V-FITC, and 7-amino actinomycin D. Cells were analyzed by three-color flow cytometry, and viable lymphocytes were gated on their forward and side light scatter characteristics. The graph shows Annexin V versus 7-amino actinomycin D staining of CD4+ cells. The numbers refer to the percentages of CD4+ LNTCs in the respective quadrants.

 
Coculture with APC that express wild-type MHC class II reduces the apoptotic index in CD4+ T lymphocytes from E137A/V142A MHC class II mutant mice, but does not restore the ability to undergo AICD

To determine whether the increased apoptotic index in resting CD4+ LNTCs from M Aßk mice was due to an intrinsic defect in the LNTCs (e.g., inability to receive signals required for survival) or rather to the lack of signals necessary for survival provided by the environment, we depleted LN cells from M Aßk mice of CD8+ and MHC class II+ cells. The resulting cell fraction was >95% CD4+. CD4+ LNTCs were cocultured for 72 h with CD4+ T cell-depleted splenocytes from W+ Aßk mice. The apoptotic index of CD4+ LNTCs from M Aßk mice was significantly lower after coculture in the presence of W+ Aßk-expressing cells (Fig. 5GoA). No difference in the percentage of apoptotic CD4+ LNTCs from W+ Aßk mice was observed whether the cells were incubated as whole LN cell preparations or as purified CD4+ LNTCs supplemented with W+ Aßk-expressing splenocytes. This result demonstrated that interactions between CD4 and MHC class II molecules were required for survival of CD4+ T lymphocytes, and suggested that in resting CD4+ T cells, signals via CD4 may block apoptosis.



View larger version (36K):
[in this window]
[in a new window]
  		FIGURE 5. Coculture with APC from W+ Aßk mice reduces the apoptotic index in CD4+ T lymphocytes from M Aßk mice. A, Whole LN cell preparations (2 x 106 cells/well; light bars) or purified CD4+ LNTCs (1–2 x 106 cells/well) supplemented with an equal number of T cell-depleted splenic APC from W+ Aßk mice were incubated for 72 h. CD4+ LNTCs were enriched to >95% purity by depletion of LN cell preparations using anti-CD8 and anti-MHC class II mAbs. The percentage of apoptotic CD4+ LNTCs was determined by two-color flow cytometry. Viable lymphocytes were gated on their forward and side light scatter characteristics. Data represent the mean ± SD of three independent experiments. The percentage of apoptotic CD4+ LNTCs in whole LN cell preparations and in W+ Aßk APC-supplemented cultures of CD4+ LNTCs was compared using Student’s unpaired t test. **, p < 0.01. Similar data were obtained when the ratio of CD4+ LNTCs to T cell-depleted APC was varied between 1:1 and 1:4. B, Whole LN cell preparations (2 x 106 cells/well; light bars) or purified CD4+ LNTCs (1–2 x 106 cells/well) supplemented with an equal number of T cell-depleted splenic APC from M Aßk or W+ Aßk mice were incubated with or without SEA (0.5 µg/ml) for 48 h. The percentage of apoptotic CD4+ LNTCs was determined by two-color flow cytometry.

 
To determine whether the inability to undergo AICD in response to SEA stimulation was also due to the lack of a signal mediated by the interaction of MHC class II molecules with CD4, we cocultured purified CD4+ LNTCs from M Aßk mice with CD4+ T cell-depleted splenic APC from W+ Aßk mice. CD4+ LNTCs from M Aßk mice were not sensitive to AICD when stimulated by SEA in the presence of APC from W+ Aßk mice (Fig. 5GoB). This result was not unexpected because the cells are defective in their ability to respond to SEA with IL-2 secretion even when stimulated by wild-type MHC class II (18). These findings suggest an intrinsic inability of CD4+ LNTCs from M Aßk mice to respond with AICD. On the other hand, CD4+ LNTCs from W+ Aßk mice were insensitive to SEA-induced apoptosis when stimulated by APC from M Aßk mice. In this experimental situation, inability of the mutant MHC class II molecules to engage CD4 presumably did not allow full activation of CD4+ LNTCs.

Exogenous IL-2 cannot protect CD4+ T lymphocytes from apoptosis in E137A/V142A MHC class II mutant mice

The apparent defect in IL-2 production by CD4+ T lymphocytes from M Aßk mice (Fig. 3Go) (18) may have contributed to their enhanced apoptosis in vivo. For example, although IL-2 promotes AICD (34, 36, 37), it can also rescue T lymphocytes from apoptosis, depending on their activation status (38, 39, 40). Therefore, we injected 8000 IU of rIL-2 twice daily for 5 days into W+ Aßk and M Aßk mice. Treatment with IL-2 led to a slight increase in the percentage of apoptotic CD4+ lymphocytes in W+ Aßk mice, whereas in M Aßk mice the percentage of apoptotic CD4+ lymphocytes was reduced after IL-2 treatment in vivo. However, these changes were small, and IL-2 injections into M Aßk mice could not diminish apoptosis in CD4+ lymphocytes to the level observed in uninjected W+ Aßk mice (data not shown).

We established that the injected dose of IL-2 was biologically effective by measuring CD25 (IL-2R{alpha}) expression in IL-2-injected and uninjected mice (Fig. 6Go). In both W+ Aßk or M Aßk mice, IL-2 treatment up-regulated CD25. This observation is in agreement with previous reports describing rescue of CD25 expression by exogenous IL-2 in lpr/lpr mice (41). However, in our M Aßk mice, regulation of CD25 expression was not solely dependent on IL-2 secretion, because constitutive expression of CD25 was higher in M Aßk than in W+ Aßk mice (Fig. 6GoA). Together, these results suggest that inability to produce IL-2 may be a contributing factor to the enhanced apoptosis of CD4+ T cells in M Aßk mice. Nevertheless, exogenous IL-2 could not substitute for the lack of CD4-MHC class II interactions.



View larger version (38K):
[in this window]
[in a new window]
  		FIGURE 6. Flow-cytometric analysis of CD25 (IL-2R{alpha}) and CD95 (Fas, APO-1) expression in CD4+ T lymphocytes from W+ Aßk (blue line) and M Aßk mice (red line). A, CD25 expression on freshly isolated CD4+ LNTCs from W+ Aßk and M Aßk mice. Mean fluorescence intensity was 58 and 123 channels for CD4+ LNTCs from W+ Aßk and M Aßk mice, respectively. Region M1 identifies cells that express high levels of CD25 (W+ Aßk, 25% CD25high; M Aßk, 56% CD25high). B, CD25 expression on CD4+ LNTCs from W+ Aßk and M Aßk mice that were injected with IL-2. Mice were injected i.p. with 8000 U of IL-2 per day for 5 days. Mean fluorescence intensity was 90 and 150 channels for CD4+ LNTCs from W+ Aßk and M Aßk mice, respectively. Region M1 identifies cells that express high levels of CD25 (W+ Aßk, 42% CD25high; M Aßk, 58% CD25high). C, CD95 expression on freshly isolated CD4+ LNTCs from W+ Aßk and M Aßk mice. Mean fluorescence intensity was 53 and 153 channels for CD4+ LNTCs from W+ Aßk and M Aßk mice, respectively. D, CD95 expression on CD4+ LNTCs from W+ Aßk and M Aßk mice after stimulation with SEA (5 µg/ml for 72 h). Mean fluorescence intensity was 105 and 167 channels for CD4+ LNTCs from W+ Aßk and M Aßk mice, respectively. LN cells were stained with anti-CD4 R-PE and either anti-CD25 FITC or anti-CD95 FITC. Viable lymphocytes were electronically gated using forward and side scatter parameters characteristic for LNTCs. Only cells staining with anti-CD4 R-PE are shown.

 
CD4+ T lymphocytes from E137A/V142A MHC class II mutant mice express higher levels of CD95 than lymphocytes from wild-type MHC class II transgenic mice

To further elucidate the mechanism responsible for enhanced apoptosis of CD4+ T lymphocytes in M Aßk mice, we measured cell surface expression of CD95 (Fas, APO-1) on CD4+ lymphocytes from W+ and M Aßk mice. Signals through CD95 initiated by CD95 ligand mediate apoptosis in susceptible cells (42, 43). Expression of CD95 was higher on CD4+ lymphocytes from M Aßk mice than on CD4+ cells from W+ Aßk mice (Fig. 6GoC). These differences remained detectable in CD4+ lymphocytes that survived in vitro culture for 72 h (not shown). In CD4+ cells from W+ Aßk mice, incubation with SEA (5 µg/ml for 72 h) strongly up-regulated CD95 expression (Fig. 6GoD). This SEA-induced up-regulation of CD95 was less pronounced in CD4+ cells from M Aßk mice. These results showed increased cell surface expression of CD95 in unstimulated CD4+ T lymphocytes from M Aßk mice, and reduced up-regulation of CD95 expression following SEA stimulation.

Because the higher cell surface expression of CD95 in CD4+ LNTCs from M Aßk mice did not necessarily imply that apoptosis was Fas mediated, we tested the susceptibility of CD4+ LNTCs to Fas signaling. We incubated LN cells from M Aßk and normal mice in culture plates that were either coated with the anti-Fas mAb Jo2 or left untreated. To determine susceptibility to Fas-mediated apoptosis, we measured the apoptotic index in CD4+ LNTCs after 24 h in culture. Treatment with Jo2 enhanced apoptosis in CD4+ LNTCs from M Aßk, but not from normal mice (Fig. 7Go). We also attempted to inhibit Fas-mediated apoptosis by blocking Fas ligand in LN cell cultures with the anti-Fas ligand mAb MFL3. Culturing LN cells from M Aßk mice with MFL3 for 24–72 h reduced the apoptotic index in CD4+ LNTCs to 87 ± 3.8% of the value measured in LNTCs incubated in the absence of MFL3 (mean ± SD of three experiments). We conclude that Fas-mediated signals contribute to the observed increased apoptosis in CD4+ LNTCs from M Aßk mice.



View larger version (65K):
[in this window]
[in a new window]
  		FIGURE 7. Resting CD4+ T lymphocytes from W+ Aßk, but not from M Aßk mice, are susceptible to CD95-mediated apoptosis. Wells of a 24-well plate were coated with the anti-CD95 mAb Jo2 by incubating 4 µg of Jo2 in 200 µl of PBS at 37°C for 2 h or left untreated. LN cells (2 x 106 cells in 800 µl of D5 media) were then added. After incubation for 20 h at 37°C and 7% CO2, the percentage of apoptotic CD4+ LNTCs was determined by two-color flow cytometry. The data are expressed as the mean ± SD of triplicate determinations, and are representative of three independent experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The E137A/V142A mutation in the Aßk chain affects only interactions between CD4 and MHC class II molecules, but not interactions between the TCR and MHC class II (12, 17, 18). Nevertheless, in M Aßk mice, which only express an E137A/V142A mutant Aßk transgene, both thymic selection of CD4+ T cells (18) and survival of peripheral CD4+ T lymphocytes were reduced. Thus, although TCR-mediated signals initiated by complexes between MHC class II and self peptides were sufficient for positive selection of some CD4+ T cells in the thymus, these signals alone could not salvage peripheral CD4+ T cells. It is unlikely that CD4+ T cells selected on M Aßk thymic epithelium had a decreased ability to signal through the TCR, because no quantitative differences in CD3 expression could be detected between M Aßk, W+ Aßk, or normal B10.A mice (data not shown). Therefore, our data suggest that CD4+ T cells require engagement of CD4 by MHC class II molecules for their long-term survival in peripheral lymphoid organs, whereas thymic selection can occur in the absence of such interactions. Thus, the CD4 coreceptor is not restricted to enhancing TCR-mediated signals, but also regulates long-term peripheral survival of T cells. Future studies must now address molecular signaling pathways that mediate this regulatory role of CD4.

Several groups of investigators have suggested that peripheral survival and self-renewal of CD4+ T cells require interactions between TCR and MHC class II molecules, presumably by periodic peripheral selection of CD4+ T cells expressing TCRs with a minimal affinity for self MHC class II molecules (35, 44, 45). However, because these investigations were conducted in MHC class II-/- mice, they could not distinguish between requirements for TCR-MHC class II and CD4-MHC class II interactions. For example, Takeda and colleagues found that naive CD4+ T cells derived from wild-type fetal thymi grafted into immunodeficient RAG-2-/- or RAG-2-/- MHC class II-/- initially proliferate to the same extent in both strains of mice, but decrease in number much faster in RAG-2-/- MHC class II-/- than in RAG-2-/- mice (35). In another study, Beutner and MacDonald showed that blood and lymphoid organs of MHC class II-/- mice cannot be reconstituted by transferring splenic CD4+ T cells (44). Furthermore, Rooke et al. determined a t1/2 of about 26 days for newly emergent CD4+ T lymphocytes in the absence of MHC class II molecules (45). These studies demonstrated that interactions with MHC class II are required for survival of CD4+ T lymphocytes in peripheral lymphoid tissues. Together, the results suggested that the degree of dependency on MHC class II interactions varies with the maturity level of CD4+ T lymphocytes. Thus, new thymic emigrant CD4+ T lymphocytes may be less dependent on interactions with MHC class II for peripheral expansion and survival than are more mature CD4+ T cells. Ours is the first report using MHC class II mutant mice in which the MHC class II molecules are incapable of interaction with CD4, but able to present Ag to the TCR. Thus, MHC class II-TCR interactions are not sufficient for the survival of resting CD4+ T cells. Furthermore, coculture of resting CD4+ LNTCs from M Aßk mice with APC that express wild-type MHC class II molecules reduced apoptosis (Fig. 5Go). We did not expect a complete rescue, because the majority of LNTCs undergoing apoptosis in the first 2 days of in vitro culture must have received apoptosis-inducing signals in vivo. Thus, our data indicate that peripheral survival of mature CD4+ T cells is regulated by CD4.

If CD4-MHC class II interactions indeed regulate the survival of resting CD4+ T cells, removal of the potential for these interactions should eventually lead to increased apoptosis in CD4+ LNTCs from normal mice. However, the reported t1/2 of about 26 days for CD4+ T lymphocytes in MHC class II-deficient mice (45) suggested that ex vivo cultures would not be adequate to address this question. Indeed, when we cocultured resting CD4+ LNTCs from W+ Aßk mice with T cell-depleted APC from M Aßk mice for up to 96 h, we did not observe an increase in apoptosis (Fig. 5GoB).

A possible mechanism responsible for the enhanced apoptosis in CD4+ LNTCs from M Aßk mice may be via the CD95-induced pathway (42, 43). CD4+ LNTCs from M Aßk mice expressed higher cell surface levels of CD95 than did CD4+ LNTCs from W+ Aßk mice (Fig. 6Go). Furthermore, mAb-mediated cross-linking of cell surface CD95 enhanced apoptosis in resting CD4+ LNTCs from M Aßk, but not from W+ Aßk mice, demonstrating susceptibility to CD95-mediated apoptosis (Fig. 7Go).

We also found that CD4+ T lymphocytes from M Aßk mice were defective with regard to the regulation of antigenic responses. This defect was manifested by deficient IL-2 secretion, a lack of AICD, and reduced up-regulation of CD95 following stimulation with SEA. However, exogenous IL-2 added in vitro could partly correct the defect to undergo AICD. Thus, the inability of CD4+ T cells from M Aßk mice to undergo AICD may be the consequence of a defective regulation of expression of cell surface receptors (e.g., CD95, CD25). The failure of exogenous IL-2 to fully restore competence to regulate CD95 and to respond with AICD to SEA stimulation may reflect a requirement for CD4 signaling. Alternatively, positive selection in the absence of CD4-MHC class II interactions may select for CD4+ T cells that possess signaling capacities on the extreme borders of the normal distribution. Again, this question can only be answered by molecular analyses of signaling pathways.

The inability to undergo AICD following SEA stimulation in vitro probably reflects a similar inability to respond to antigenic stimulation with AICD in vivo. We have shown previously that in M Aßk mice, primary and secondary immunizations with keyhole limpet hemocyanin expand Ag-responsive CD4+ T cells that secrete enhanced amounts of IFN-{gamma} following in vitro restimulation. In W+ Aßk mice, a primary keyhole limpet hemocyanin immunization primes CD4+ T cells to respond to in vitro restimulation with IFN-{gamma} secretion to the same extent as in M Aßk mice, but a secondary immunization causes a drastic reduction in the ability to secrete IFN-{gamma} in response to in vitro restimulation (18). This difference in IFN-{gamma} secretion after a secondary stimulation with Ag probably reflects in vivo AICD in W+ Aßk mice, but not in M Aßk mice.

In conclusion, we report that CD4-MHC class II interactions are required for maintenance of CD4+ T cells in peripheral lymphoid organs and for AICD. These observations suggest that signals through CD4 independent of or in combination with TCR-mediated signals facilitate long-term survival of peripheral CD4+ T cells. Furthermore, CD4+ T lymphocytes selected in the absence of CD4-MHC class II interactions appear defective in their ability to regulate antigenic responses, as exemplified by their divergent regulation of CD25 and CD95, and their lack of IL-2 secretion following stimulation with SEA.


   Acknowledgments
 
We thank Drs. Nancy Van Houten and Lynn Soong for discussions and critical comments on the manuscript, Wenhong Zhou and Timothy L. Denning for discussions, and Mardelle Susman for editorial assistance.


   Footnotes
 
1 R.M. was supported by the Direccion General Cientifica y Tecnica of Spain (PF9570796464). This work was supported by grants from the American Heart Association, Texas Affiliate (95G-662), and the American Heart Association (9750717N) to R.K. Back

2 Address correspondence and reprint requests to Dr. Rolf König, Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1070. E-mail address: Back

3 Abbreviations used in this paper: AICD, activation-induced cell death; LN, lymph node; LNTC, LN T cell; SEA, staphylococcal enterotoxin A. Back

Received for publication November 5, 1998. Accepted for publication March 3, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Teh, H.-S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluethmann, H. von Boehmer. 1988. Thymic major histocompatibility antigens and the {alpha}ß T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229.[Medline]
  2. Berg, L. J., A. M. Pullen, B. Fazekas de St. Groth, D. Mathis, C. Benoist, M. M. Davis. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58:1035.[Medline]
  3. Aldrich, C. J., R. E. Hammer, S. Jones-Youngblood, U. Koszinowski, L. Hood, I. Stroynowski, J. Forman. 1991. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the {alpha}3 domain of MHC I molecules. Nature 352:718.[Medline]
  4. Ingold, A. L., C. Landel, C. Knall, G. A. Evans, T. A. Potter. 1991. Co-engagement of CD8 with the T cell receptor is required for negative selection. Nature 352:721.[Medline]
  5. Killeen, N., A. Moriarty, H. S. Teh, D. R. Littman. 1992. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J. Exp. Med. 176:89.[Abstract/Free Full Text]
  6. Engleman, E. G., C. J. Benike, F. C. Grumet, R. L. Evans. 1981. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J. Immunol. 127:2124.[Abstract]
  7. Spits, H., J. Borst, C. Terhorst, J. E. de Vries. 1982. The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens. J. Immunol. 129:1563.[Medline]
  8. Bierer, B. E., B. P. Sleckman, S. E. Ratnofsky, S. J. Burakoff. 1989. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu. Rev. Immunol. 7:579.[Medline]
  9. Connolly, J. M., T. A. Potter, E. M. Wormstall, T. H. Hansen. 1988. The Lyt-2 molecule recognizes residues in the class I {alpha}3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 168:325.[Abstract/Free Full Text]
  10. Potter, T. A., T. V. Rajan, R. F. Dick, J. A. Bluestone. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 337:73.[Medline]
  11. Salter, R. D., R. J. Benjamin, P. K. Wesley, S. E. Buxton, T. P. J. Garrett, C. Clayberger, A. M. Krensky, A. M. Norment, D. R. Littman, P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the {alpha}3 domain of HLA-A2. Nature 345:41.[Medline]
  12. König, R., L. Y. Huang, R. N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796.[Medline]
  13. König, R., X. Shen, R. N. Germain. 1995. Involvement of both MHC class II {alpha} and ß chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.[Abstract/Free Full Text]
  14. Connolly, J. M., T. H. Hansen, A. L. Ingold, T. A. Potter. 1990. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I {alpha}3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 87:2137.[Abstract/Free Full Text]
  15. Janeway, C. A.. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645.[Medline]
  16. Ravichandran, K. S., T. L. Collins, S. J. Burakoff. 1996. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 205:47.[Medline]
  17. Riberdy, J. M., E. Mostaghel, C. Doyle. 1998. Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4+ T cells in vivo. Proc. Natl. Acad. Sci. USA 95:4493.[Abstract/Free Full Text]
  18. Gilfillan, S., X. Shen, R. König. 1998. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4. J. Immunol. 161:6629.[Abstract/Free Full Text]
  19. Boehme, S. A., L. Zheng, M. J. Lenardo. 1995. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 155:1703.[Abstract]
  20. Shen, X., R. König. 1998. Regulation of T cell immunity and tolerance in vivo by CD4. Int. Immunol. 10:247.[Abstract/Free Full Text]
  21. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sékaly, T. H. Finkel. 1992. Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J .Exp. Med. 176:1099.[Abstract/Free Full Text]
  22. Oyaizu, N., T. W. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman, S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392.[Abstract/Free Full Text]
  23. Wang, L., B. B. Gelman, R. König, M. W. Cloyd. 1999. A novel mechanism of CD4 lymphocyte depletion involves HIV’s effects on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. J. Immunol. 162:268.[Abstract/Free Full Text]
  24. Algeciras, A., D. H. Dockrell, D. H. Lynch, C. Paya. 1998. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J .Exp. Med. 187:711.[Abstract/Free Full Text]
  25. Kouskoff, V., H. J. Fehling, M. Lemeur, C. Benoist, D. Mathis. 1993. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166:287.[Medline]
  26. Shen, X., B. Hu, P. McPhie, X. Wu, A. Fox, R. N. Germain, R. König. 1996. Peptides corresponding to CD4 interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo. J. Immunol. 157:87.[Abstract]
  27. Schmid, I., W. J. Krall, C. H. Uittenbogaart, J. Braun, J. V. Giorgi. 1992. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204.[Medline]
  28. Lecoeur, H., E. Ledru, M. C. Prevost, M. L. Gougeon. 1997. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209:111.[Medline]
  29. Kawabe, Y., A. Ochi. 1991. Programmed cell death and extrathymic reduction of Vß8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245.[Medline]
  30. Wang, R., K. M. Murphy, D. Y. Loh, C. Weaver, J. H. Russell. 1993. Differential activation of antigen-stimulated suicide and cytokine production pathways in CD4+ T cells is regulated by the antigen-presenting cell. J. Immunol. 150:3832.[Abstract]
  31. Huang, L., G. Soldevila, M. Leeker, R. A. Flavell, I. N. Crispe. 1994. Liver is the site of T cell destruction during peripheral deletion. Immunity 1:741.[Medline]
  32. Vermes, I., C. Haanen, H. Steffens-Nakken, C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39.[Medline]
  33. Verhoven, B., R. A. Schlegel, P. Williamson. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1597.[Abstract/Free Full Text]
  34. Lenardo, M. J.. 1991. Interleukin-2 programs mouse {alpha}ß T lymphocytes for apoptosis. Nature 353:858.[Medline]
  35. Takeda, S., H. R. Rodewald, H. Arakawa, H. Bluethmann, T. Shimizu. 1996. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity 5:217.[Medline]
  36. Fournel, S., L. Genestier, E. Robinet, M. Flacher, J. P. Revillard. 1996. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157:4309.[Abstract]
  37. Zheng, L., C. L. Trageser, D. M. Willerford, M. J. Lenardo. 1998. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160:763.[Abstract/Free Full Text]
  38. Gougeon, M. L., H. Lecoeur, A. Dulioust, M. G. Enouf, M. Crouvoiser, C. Goujard, T. Debord, L. Montagnier. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:3509.[Abstract]
  39. Gonzalez-Garcia, A., I. Merida, A. C. Martinez, A. C. Carrera. 1997. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 272:10220.[Abstract/Free Full Text]
  40. Gougeon, M. L., H. Lecoeur, F. Boudet, E. Ledru, S. Marzabal, S. Boullier, R. Roue, S. Nagata, J. Heeney. 1997. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J. Immunol. 158:2964.[Abstract]
  41. Radvanyi, L. G., K. Raju, D. Spaner, G. B. Mills, R. G. Miller. 1998. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Cell. Immunol. 183:1.[Medline]
  42. Nagata, S., P. Golstein. 1995. The Fas death factor. Science 267:1449.[Abstract/Free Full Text]
  43. Van Parijs, L., A. Ibraghimov, A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.[Medline]
  44. Beutner, U., H. R. MacDonald. 1998. TCR-MHC class II interaction is required for peripheral expansion of CD4 cells in a T cell-deficient host. Int. Immunol. 10:305.[Abstract/Free Full Text]
  45. Rooke, R., C. Waltzinger, C. Benoist, D. Mathis. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123.[Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
Z. Tatari-Calderone, J. L. Brogdon, K. W. Tinsley, A. Ramezani, and D. Leitenberg
CD4-Dependent Signaling Is Required for a Late Checkpoint during Th2 Development Associated with Resistance to Activation-Induced Cell Death
J. Immunol., November 1, 2005; 175(9): 5629 - 5636.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Stoicov, X. Cai, H. Li, K. Klucevsek, J. Carlson, R. Saffari, and J. Houghton
Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation
Infect. Immun., October 1, 2005; 73(10): 6311 - 6321.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. W. Wolkersdorfer, C. Marx, J. Brown, S. Schroder, M. Fussel, E. P. Rieber, E. Kuhlisch, G. Ehninger, and S. R. Bornstein
Prevalence of HLA-DRB1 Genotype and Altered Fas/Fas Ligand Expression in Adrenocortical Carcinoma
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1768 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Q. Wang, J. Strong, and N. Killeen
Homeostatic Competition Among T Cells Revealed by Conditional Inactivation of the Mouse Cd4 Gene
J. Exp. Med., December 10, 2001; 194(12): 1721 - 1730.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Wang, L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen
CD4 Promotes Breadth in the TCR Repertoire
J. Immunol., October 15, 2001; 167(8): 4311 - 4320.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Strong, Q. Wang, and N. Killeen
Impaired survival of T helper cells in the absence of CD4
PNAS, February 27, 2001; 98(5): 2566 - 2571.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maroto, R.
Right arrow Articles by König, R.
Right arrow Search for Related Content